https://www.marketscreener.com/quote/stock/ASTELLAS-PHARMA-INC-6491262/news/Astellas-Pharma-European-Commission-Approves-Astellas-XOSPATA-gilteritinib-as-a-Monotherap-29453905/?utm_source=telegram&utm_medium=social&utm_campaign=share